Primary Article
Treatment of Gastrointestinal Cancer: The Southeastern Cancer Study Group Experience, 1979 to 1983
Abstract
ABSTRACT: The treatment of gastrointestinal cancer was studied in 20 phase I, II, and III clinical trials from 1979 to 1983 at 30 member institutions of the Southeastern Cancer Study Group (SECSG). These studies used both new and commercially available drugs, as well as surgery and/or radiation therapy in 1,087 patients. No significant benefit was seen from 18 agents, and one agent is still under evaluation. Unfortunately, no recommendations can be drawn from these studies that would alter presently accepted methods of management. Adenocarcinoma of the gastrointestinal tract remains a major challenge to tumor biologists and clinical oncologists because it is generally resistant to chemotherapy and radiation therapy, yet common enough to represent a vital public health concern in America.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.